Empagliflozin in Heart Failure with a Preserved Ejection Fraction

  Рет қаралды 4,714

InsideCardiology

InsideCardiology

Күн бұрын

Professor Thomas Lüscher discusses the paper of the week with Brian Halliday
Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction are uncertain.
#InsideCardiology

Пікірлер: 3
@richt6353
@richt6353 Жыл бұрын
Thank You for this NEWS!
@Nikesnipe
@Nikesnipe 2 жыл бұрын
Great Overview
@dr.mamunurrashid25
@dr.mamunurrashid25 2 жыл бұрын
I want to know about renal effect of this drug.
Assessing Heart Failure with Preserved Ejection Fraction
14:25
EMPEROR Preserved | EMPEROR Pooled Trial Results
9:42
AHAScience
Рет қаралды 4,8 М.
Пранк пошел не по плану…🥲
00:59
Саша Квашеная
Рет қаралды 7 МЛН
Slow motion boy #shorts by Tsuriki Show
00:14
Tsuriki Show
Рет қаралды 10 МЛН
ВОДА В СОЛО
00:20
⚡️КАН АНДРЕЙ⚡️
Рет қаралды 34 МЛН
Aspirin
6:52
InsideCardiology
Рет қаралды 897
SGLT2 Inhibitors and Heart Failure
8:15
Harvard Medical School Continuing Education
Рет қаралды 22 М.
Professor Milton Packer - 'Heart failure - are there limits to anti-diabetic therapy with SGLT2'
38:55
At the Limits - Leading Medical Education
Рет қаралды 14 М.
Vascular Dementia: A preventable cause of cognitive decline
8:59
InsideCardiology
Рет қаралды 18 М.
How SGLT2 Inhibitors Protect The Kidney
16:24
Conan Liu, M.D.
Рет қаралды 15 М.
SGLT-2 inhibitors in Heart Failure
34:28
Cardio-Ed
Рет қаралды 7 М.
Heart Failure with Mildly Reduced or Preserved Ejection Fraction (Scott D. Solomon MD) June 16, 2022
1:01:32
Пранк пошел не по плану…🥲
00:59
Саша Квашеная
Рет қаралды 7 МЛН